Age-related macular degeneration (AMD) is a significant factor contributing to serious vision
loss in adults above 50. The presence of posterior segment barriers serves as chief …

Bio-compatible, bio-degradable, and bio-available excipients are of critical interest for drug
delivery systems. Cellulose and its derivative-based excipients have been well studied due …

Introduction: The development of ophthalmic formulations able to deliver hydrophilic and
hydrophobic drugs to the inner structures of the eye and restore the preocular tear film has …

Age-related macular degeneration (AMD) is the leading cause of vision loss in geriatric
population. Intravitreal (IVT) injections are popular clinical option. Biologics and small …

Fundus neovascularization diseases are a series of blinding eye diseases that seriously
impair vision worldwide. Currently, the means of treating these diseases in clinical practice …

Purpose The retina is continually exposed to free radicals from its rich blood supply,
numerous mitochondria, and photons of light which strike its surface. Most pathological …

Age-related macular degeneration (AMD), a degenerative eye disease, is the major cause of
irreversible loss of vision among individuals aged 50 and older. Both genetic and …

Age-related macular degeneration (AMD) is the third leading cause worldwide blindness
that causes permanent central vision impairment in older people. Over the past few years …

Liposomes, lipid-based vesicular systems, have attracted major interest as a means to
improve drug delivery to various organs and tissues in the human body. Recent literature …

Rationale Age-related macular degeneration (AMD) is one of the leading causes of
blindness among the elderly. Due to its complex etiology, current treatments have been …